-+ 0.00%
-+ 0.00%
-+ 0.00%

Gossamer Bio says $18.95 million of 5% convertible notes due 2027 remain after exchange offer

PUBT·06/17/2026 12:02:13
Listen to the news
Gossamer Bio says $18.95 million of 5% convertible notes due 2027 remain after exchange offer
  • Gossamer Bio completed an exchange offer for its 5.00% Convertible Senior Notes due 2027.
  • USD 181.05 million principal was tendered; no additional notes were submitted by June 16, 2026.
  • Remaining outstanding principal totals USD 18.95 million.
  • Exchanged notes were replaced with a pro rata mix of new 7.50% Convertible Senior Secured First Lien Notes due 2030 and equity-linked securities.
  • Settlement for early tenders occurred June 4, 2026; the old note indenture was amended to strip most restrictive covenants.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gossamer Bio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260617149554) on June 17, 2026, and is solely responsible for the information contained therein.